ANDA 65163, held by Heritage Pharma. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 65163 (Doxycycline Hyclate), held by Heritage Pharma, was first approved by FDA on May 13, 2005, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 13, 2005 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxycycline HyclateEQ 20MG BASE · tablet;oral | Doxycycline Hyclate | Discontinued |
| Mar 31, 2025 | Supplement 14Labeling · Standard review | Approved | None posted |
| Mar 12, 2025 | Supplement 12Labeling · Standard review | Approved | None posted |
| Mar 12, 2025 | Supplement 13Labeling · Standard review | Approved | None posted |
| May 13, 2005 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters